Amniotic Membrane Therapy in Ocular Surface Disease: Introduction

Article Sidebar

pdf
Published: May 9, 2019
DOI: https://doi.org/10.22374/jded.v2i1.14
Keywords:
Amniotic Membrane Therapy, Ocular Surface Disease

Main Article Content

Nicholas Colatrella

Abstract

The goal of this publication is to show the many uses for AMs in treating ocular surface disease and to provide a resource for their use in clinical practice.

Downloads

Download data is not yet available.

Article Details

Issue
Vol. 2 No. 1 (2019): JDEOSD (Special Issue)
Section
Articles

Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.

Author Biography

Nicholas Colatrella

Dr. Nicholas Colatrella is a residency trained optometrist, who is the medical director and owner of PineCone Vision Center.  Dr. Colatrella is board certified by the American Board of Optometry and the American Board of Certification in Medical Optometry.  Dr. Colatrella received his Bachelor of Science degree from Old Dominion University in Norfolk, VA, and his Doctor of Optometry with honors from the Illinois College of Optometry in Chicago.  He completed his residency in ocular disease at the Veterans Administration Medical Center in Cleveland, Ohio and served as the director of operations at Northeast Ohio Eye Surgeons.  
Dr. Colatrella is a fellow in the American Academy of Optometry, past Chair of its disease section and a founding chair of the Anterior Segment Section.  He was also the first of two Diplomates in Anterior Segment Disease of the American Academy of Optometry.  He is a member of the American Optometric Association, Past President of both the Minnesota Optometric Association and the Illinois College of Optometry Alumni Council.  He is an InfantSEE® Provider and has served as an examiner for the National Board of Examiners in Optometry.  He has been published several times and lectures nationally on various topics including LASIK, cataracts, pharmacology, dry eye and corneal diseases.  He is an adjunct professor for several Colleges of Optometry and routinely mentors optometry student externs.  Locally, he has served on the boards for the Sartell Area Chamber of Commerce and the City of Sartell’s Economic Development Commission.  Dr. Colatrella has proudly accepted numerous awards and was honored to accept the “Young Optometrist of the Year” award both in Ohio and Minnesota.  He was also acknowledged as one of Best and Brightest “Forty under 40” in the eye care industry by Vision Monday Magazine and humbly accepted the “Sartell Business of the Year” award.  Dr. Colatrella enjoys his children, biking, running, tri /duathlons, fantasy football and home improvement.

References

1. Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface dysfunctions. Br J Ophthalmol 2013;97:955–60.
2. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45(Suppl. 2):S203–10.
3. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul. Surf 2013;11:246–58.
4. Muri M, Moshirfar M. Birdsong O. 2018. Amniotic membrane extract and eye drops: a review of literature and clinical application, Clin Ophthalmol 2018;12:1105–12.